Health2047 Inc., a Silicon Valley-based health IT and commercialization venture, has announced the appointment of industry experts Charles Hoyng, Jay Kaminski, Georgia Papathomas, and Craig Taylor to its advisory board. With the help of them, health2047 will develop and commercialize solutions for healthcare problems.
Health2047 Inc. and its strategic partners are committed to bringing change in healthcare by creating solutions for these four problem areas, data liquidity, chronic care, radical productivity, and healthcare value. Akiri Switch is the first spin-out of health2047 that is building a cloud-based, peer-to-peer network to enable secured data exchange across the healthcare sector.
First Mile Care is the second start-up of health2047. It is a preventive, chronic care firm, which is building an affordable, scalable, and sustainable platform to reverse pre-diabetes.
Health2047 has announced the start-up of zing health, which will offer a tech-enabled community care model.
Health2047 announced the expansion of the advisory board in July 2019. Charles, Jay, Georgia, and Craig have admired industry experts whose vast knowledge and experience will undoubtedly help Health2047 improve the $3 trillion healthcare sector. The new members joining Health2047 advisory team are
Charles Hoyng
Charles is an advisory at health2047. Hoyng brings 30 years of experience in counseling the development, protection, manufacture, and distribution of pharmaceutical and medical diagnostic products.
Jay Kaminski
Kaminski is an advisory at health2047 and a Chief Operating Officer at Cellularity. Previously, he has worked with Celgene, which is a partner with health2047 in transmitting secure data among healthcare providers. Kaminski brings nearly 30 years of experience in the pharmaceutical and biotechnology industry.
Georgia Papathomas
Papathomas is an investor, advisor, and board member in health2047. He brings over 40 years of experience in life sciences, telecommunications, and technology. Before this, she was serving Johnson & Johnson as the Senior Vice President and Global Head of Data Sciences. She also has worked as CIO and a member of the Group Operating Committee (GOC) of Johnson & Johnson Pharmaceuticals.
Health2047 